More articles from INTEGRATED Session: Advance Management of Thyroid Cancer

You have access
What is the impact of pre-ablation 131-I scintigraphy with SPECT-CT on thyroid cancer management?
Ka Kit Wong, Nazanene Esfandiari and Anca Avram

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 144;
You have access
Radioactive iodine-131 induces human thyrocyte cell line HTori 3 cell apoptosis and G2/M arrest in a p53-independent pathway
Weixiao Zhang, Rui Gao, Yan Yu, Kun Guo and Yan Liu

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 142;
You have access
Salivary gland scintigraphy to detect chronic salivary gland damages after high dose radioiodine therapy for thyroid cancer: Correlation with sialography
Kunihiro Nakada, Yasusi Satou, Masayuki Sakurai and Keiichi Ohmori

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 145;
You have access
The oxyphilic variants of differentiated thyroid carcinoma: Analysis of 135 patients with follicular Huerthle cell carcinoma and papillary thyroid carcinoma with Huerthle cells
Mona Mustafa, Harun Ilhan, Julia Geisler, Peter Bartenstein and Axel Rominger

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 147;
You have access
Clinical value of whole body [18F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer
Jinjin Jiang, Zhongyi Yang, Yongping Zhang, Jing Xue, Xiaoping Xu, Wei Shi, Silong Hu, Zhifeng Yao, Beiling Zhu and Duanshu Li

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 143;
You have access
Predictive value of FDG PET at initial radioiodine therapy for survival of high-risk patients with differentiated thyroid cancer
Florian Gaertner, Shozo Okamoto, Tohru Shiga, Yoichi Ito, Yuko Uchiyama, Osamu Manabe, Naoya Hattori and Nagara Tamaki

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 146;

Main menu

User menu

Search

More articles from INTEGRATED Session: Advance Management of Thyroid Cancer